In Brief This Week: US Department of Defense, PerkinElmer; Luminex; Source BioScience, Inverclyde Biologicals; Crescendo Bioscience; More | GenomeWeb

NEW YORK (GenomeWeb News) – The US Department of Defense said recently that PerkinElmer Genetics has been awarded a maximum $9.7 million modification exercising the second option year of a one-year base contract with four one-year option periods for newborn screening services. "The modification is a firm-fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity, performance-based service contract," according to DoD. May 6, 2014 is the performance completion date. PerkinElmer did not reply to a message seeking additional information.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.